Alpha Tau Announces Multiple Corporate Updates Ahead of
- Medicines and Healthcare products Regulatory Agency of the United Kingdom approves clinical trial in squamous cell carcinoma of the vulva at Addenbrookes...
Stay updated with breaking news from Alpha Da. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Medicines and Healthcare products Regulatory Agency of the United Kingdom approves clinical trial in squamous cell carcinoma of the vulva at Addenbrookes...
JERUSALEM, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer...
JERUSALEM, Sept. 01, 2022 -- Alpha Tau Medical Ltd. , the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that Peter Melnyk, a member of its board of... | September 1, 2022
30.08.2022 - JERUSALEM, Aug. 30, 2022 (GLOBE NEWSWIRE) - Alpha Tau Medical Ltd. (Nasdaq: DRTS) ('Alpha Tau'), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, today announced the Company will participate in person at three upcoming ...
(2022-07-05 | NDAQ:DRTS) Alpha Tau Hosting Key Opinion Leader Meeting on Alpha DaRT Clinical Trials